Skip to main content
. 2017 Feb 22;13(4):2607–2614. doi: 10.3892/ol.2017.5761

Figure 1.

Figure 1.

Anti-proliferative effects of FFJ-3 and mollugin. Schematic diagrams of the chemical structure of (A) mollugin and (B) FFJ-3. Survival rate of HepG2, A549 and MCF-7 cells following treatment with (C) mollugin and (D) FFJ-3. Cells were exposed to the compounds for 48 h prior to the MTT assay. *P<0.05, **P<0.01 vs. the corresponding untreated control groups.